Jointown Pharmaceutical Group Co., Ltd.
600998
Pozycja w akcjach
#4344
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution... Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.
Cena akcji
$0.72022201
Kapitalizacja rynkowa
$3.63B
Zmiana (1 dzień)
-0.80%
Zmiana (1 rok)
4.44%
Kraj
CN
Handel Jointown Pharmaceutical Group Co., Ltd. (600998)
Kategoria
Healthcare
Zyski dla Jointown Pharmaceutical Group Co., Ltd. (600998)
Zyski w Jun 2026 TTM: $416.06M
Według najnowszych raportów finansowych Jointown Pharmaceutical Group Co., Ltd., obecny zysk firmy wynosi $416.06M. W roku 2023 firma osiągnęła zysk w wysokości $422.52M, wzrost w porównaniu do zysku z roku 2022, który wynosił $411.44M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Jointown Pharmaceutical Group Co., Ltd. od 2007 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $416.06M | -16.51% |
| 2024 | $498.34M | 17.95% |
| 2023 | $422.52M | 2.69% |
| 2022 | $411.44M | -22.25% |
| 2021 | $529.16M | -20.24% |
| 2020 | $663.43M | 99.34% |
| 2019 | $332.81M | 25.04% |
| 2018 | $266.16M | -10.03% |
| 2017 | $295.83M | 85.77% |
| 2016 | $159.25M | 8.19% |
| 2015 | $147.19M | 21.01% |
| 2014 | $121.63M | 21.59% |
| 2013 | $100.03M | 12.91% |
| 2012 | $88.59M | 14.06% |
| 2011 | $77.67M | 7.20% |
| 2010 | $72.46M | 31.02% |
| 2009 | $55.30M | 43.01% |
| 2008 | $38.67M | 39.46% |
| 2007 | $27.73M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $6.46B | 1,452.19% |
US
|
|
| - | - |
US
|
|
| $2.17B | 422.52% |
US
|
|
| - | - |
US
|
|
| $708.86M | 70.38% |
AU
|
